We are live on ! Find out more
MIRM icon

Mirum Pharmaceuticals
MIRM

104 hedge funds and large institutions have $650M invested in Mirum Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 47 increasing their positions, 25 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

206% more call options, than puts

Call options by funds: $422K | Put options by funds: $138K

88% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 25

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

3% less capital invested

Capital invested by funds: $673M → $650M (-$23.1M)

2.76% less ownership

Funds ownership: 93.18% → 90.42% (-2.8%)

7% less funds holding

Funds holding: 112 → 104 (-8)

30% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 23

Holders
104
Holders Change
-8
Holders Change %
-7.14%
% of All Funds
1.67%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.1%
New
16
Increased
47
Reduced
25
Closed
23
Calls
$422K
Puts
$138K
Net Calls
+$284K
Net Calls Change
-$80K

Top Buyers

1
EAM
Eventide Asset Management
Massachusetts
+$15.5M
2
State Street
State Street
Massachusetts
+$15.2M
3
TCM
Tang Capital Management
California
+$13.2M
4
Citadel Advisors
Citadel Advisors
Florida
+$9.55M
5
BlackRock
BlackRock
New York
+$7.66M

Top Sellers

1
Franklin Resources
Franklin Resources
California
-$22.4M
2
CCM
Cadian Capital Management
New York
-$19.5M
3
Victory Capital Management
Victory Capital Management
Texas
-$14.6M
4
FLAM
First Light Asset Management
Minnesota
-$11M
5
PCH
Polar Capital Holdings
United Kingdom
-$6.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
SPIA
76
Steward Partners Investment Advisory
New York
$185K +$42.5K +2,150 +29%
AIG
77
American International Group
New York
$170K +$2.39K +121 +1%
MIM
78
MetLife Investment Management
New Jersey
$164K – – –
Zurich Cantonal Bank
79
Zurich Cantonal Bank
Switzerland
$151K +$118K +5,945 +334%
Legal & General Group
80
Legal & General Group
United Kingdom
$142K – – –
LSA
81
Leonteq Securities AG
Switzerland
$97.5K +$98.8K +5,000 New
Simplex Trading
82
Simplex Trading
Illinois
$60K +$58.8K +2,976 +2,439%
AB
83
Amalgamated Bank
New York
$55K – – –
Royal Bank of Canada
84
Royal Bank of Canada
Ontario, Canada
$53K +$47.2K +2,387 +688%
Lazard Asset Management
85
Lazard Asset Management
New York
$47K – – –
TRCT
86
Tower Research Capital (TRC)
New York
$45K +$2.35K +119 +5%
SIM
87
Sandia Investment Management
Massachusetts
$42.9K – – –
EWM
88
Endurance Wealth Management
Rhode Island
$38K +$24.8K +1,254 +179%
AIP
89
Ameritas Investment Partners
Nebraska
$25.6K – – –
Allspring Global Investments
90
Allspring Global Investments
North Carolina
$21.1K -$474 -24 -2%
MLICM
91
Metropolitan Life Insurance Company (MetLife)
New York
$19.1K – – –
Fidelity Investments
92
Fidelity Investments
Massachusetts
$14.2K +$1.03K +52 +8%
AF
93
Allworth Financial
California
$12.3K – – –
PA
94
Parallel Advisors
California
$7.8K – – –
CUAMC
95
China Universal Asset Management Company
China
$7.29K +$573 +29 +8%
HWM
96
HighMark Wealth Management
Minnesota
$5.17K -$3.95K -200 -43%
LC
97
Lindbrook Capital
California
$4.62K +$4.68K +237 New
Daiwa Securities Group
98
Daiwa Securities Group
Japan
$3K +$1.17K +59 +66%
US Bancorp
99
US Bancorp
Minnesota
$2.73K +$2.77K +140 New
S
100
SignatureFD
Georgia
$449 +$455 +23 New
1 2 3
4
5

MIRM Hedge Fund Activity: Q4 2022 in Review

104 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q4 2022, worth a combined $650M — down 3.4% from $673M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of MIRM and 16 opened new positions — a net loss of 7 holders — while 25 trimmed existing stakes and 47 added.

The largest buyer was Eventide Asset Management, adding an estimated $15.5M. The largest seller was Franklin Resources, cutting an estimated $22.4M.

  • 104 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q4 2022, down from 112 in Q3 2022.
  • Funds reported $650M of Mirum Pharmaceuticals stock for Q4 2022, down 3.4% quarter-over-quarter.
  • 16 funds opened new Mirum Pharmaceuticals positions in Q4 2022 and 23 closed out, a net change of -7 holders.
  • The largest Mirum Pharmaceuticals buyer in Q4 2022 was Eventide Asset Management, an estimated $15.5M added.
  • The largest Mirum Pharmaceuticals seller in Q4 2022 was Franklin Resources, an estimated $22.4M sold.

Based on aggregated 13F filings for Q4 2022.